How to Use Infusion Therapy for Alzheimer’s

Alzheimer’s disease was once thought to be untreatable. But, new research has given us hope. Infusion therapy for Alzheimer’s is a big step forward, mainly for those in the early stages. Treatments like lecanemab and donanemab have shown they can slow down cognitive decline.

These treatments involve regular intravenous infusions that target the root cause of Alzheimer’s. They work by reducing brain amyloid plaques. Lecanemab is given every two weeks for up to 18 months. Donanemab is given monthly, and treatment can stop once amyloid levels drop below a certain level.

Key Takeaways

• Infusion therapy offers new hope for early-stage Alzheimer’s patients.
• Lecanemab and donanemab are two promising treatments.
• These therapies slow cognitive decline and reduce amyloid plaques.
• Administration schedules vary between lecanemab and donanemab.
• Treatment plans are tailored based on individual patient needs.

Understanding Infusion for Dementia: Available Treatments and How They Work

New treatments for Alzheimer’s include infusion therapies. These therapies send medicine straight to the brain through the veins. This method ensures the drug reaches the brain in high amounts.

Two FDA-Approved Monoclonal Antibody Infusions

Lecanemab and donanemab are two monoclonal antibody infusions approved by the FDA. They target amyloid-beta plaques, which are key to Alzheimer’s disease.

These infusions are given through a vein in a doctor’s office. How often and for how long depends on the treatment plan.

The Science Behind Amyloid-Beta Targeting

Amyloid-beta plaques harm the brain and cause memory loss in Alzheimer’s patients. Monoclonal antibodies like lecanemab and donanemab help remove these plaques from the brain.

Expected Results and Clinical Trial Data

Studies show lecanemab and donanemab reduce amyloid plaques and slow down memory loss. Here’s a summary of the trial results:

These findings suggest infusion treatments can slow down Alzheimer’s disease. This brings hope to patients and their families.

How to Access and Receive Alzheimer’s Infusion Treatment

Getting Alzheimer’s infusion treatment involves several important steps. Patients and caregivers need to understand these steps well. This includes knowing how to start and manage treatment.

Step 1: Determine Your Eligibility for Treatment

To get Alzheimer’s infusion treatments, like lecanemab, you need to meet certain criteria. You should have mild cognitive impairment or mild dementia from Alzheimer’s. Also, you must have amyloid pathology confirmed by PET or CSF testing. A recent MRI is also needed before starting treatment. It’s important to talk to a healthcare provider to see if you qualify.

Step 2: Get Proper Diagnostic Testing and Confirmation

Diagnostic tests are key to confirming Alzheimer’s disease and checking if infusion therapy is right for you. These tests include:

• Amyloid PET scans or CSF testing to confirm amyloid pathology
• MRI scans to rule out other causes of cognitive decline and to establish a baseline
• Cognitive and functional assessments to determine the stage of Alzheimer’s

These tests help healthcare providers decide if infusion therapy is a good choice for you.

Step 3: Schedule Your Infusion Appointments

After confirming eligibility, the next step is to schedule infusion appointments. This includes:

1. Coordinating with your healthcare provider to determine the frequency and duration of infusions
2. Arranging for infusion therapy at a suitable healthcare facility
3. Planning for transportation and support during treatment sessions

It’s important to stick to the infusion plan to get the most out of the treatment.

Step 4: Monitor Treatment Progress and Manage Side Effects

It’s important to keep an eye on how well the treatment is working and manage any side effects. This includes:

• Regular follow-up appointments with your healthcare provider
• Monitoring for side effects like infusion-related reactions or amyloid-related imaging abnormalities (ARIA)
• Adjusting the treatment plan as needed based on how well you’re doing and how you’re feeling

Managing side effects and keeping an eye on treatment progress can help make the therapy more effective.

Conclusion

Infusion therapy for Alzheimer’s is a big step forward in treating dementia. We’ve looked at treatments like FDA-approved monoclonal antibody infusions. These treatments aim to remove amyloid-beta from the brain.

New treatments for Alzheimer’s are being developed. This means better options for patients and their families. Infusion therapy for Alzheimer’s is becoming a key part of care, bringing new hope.

Knowing how to get Alzheimer’s infusion treatment is important. It’s a new way to help those with the disease. We’re excited about the role infusion therapy will play in future treatments. Ongoing research will help us understand Alzheimer’s better.

FAQ

References

New England Journal of Medicine. Evidence-Based Medical Insight. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMoa2212948